FindTrial
Sign In

The role of prednisone in subacute pain after total knee arthroplasty

Oral low-dose prednisone for subacute pain after total knee arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021226
Enrollment
Unknown
Registered
2019-02-02
Start date
2018-02-10
Completion date
Unknown
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee arthritis

Interventions

Two groups:Oral low dose prednisone for 14 days

Sponsors

Xinqiao Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
48 Years to 81 Years

Inclusion criteria

Inclusion criteria: Primary knee arthroplasty, aged 40-80 years old, with sufficient cognitive ability, willing to participate in the test, can comply with the agreement to complete the test.

Exclusion criteria

Exclusion criteria: Bilateral knee arthroplasty, revision surgery, serious knee valgus deformity, glucocorticoid allergy, alcohol, drug abuse, active gastrointestinal ulcer, etc.

Design outcomes

Primary

MeasureTime frame
pain after total knee arthroplasty;—

Secondary

MeasureTime frame
Consumption of analgesics;—

Countries

China

Contacts

Public ContactCheng Xingwang

Xinqiao Hospital of Army Medical University

cxw028@126.com+86 15310328816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026